Search alternatives:
significantly increased » significant increase (Expand Search)
significant decrease » significant increase (Expand Search)
significant i » significant _ (Expand Search), significant co (Expand Search), significant 17 (Expand Search)
i decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
Showing 19,421 - 19,440 results of 21,342 for search '(( ((significant decrease) OR (significantly increased)) decrease ) OR ( significant i decrease ))', query time: 0.68s Refine Results
  1. 19421
    Video 3_Cardiac contractility modulation to enhance optimized medical therapy and improve cardiac remodeling in advanced heart failure: a case report.avi

    Video 3_Cardiac contractility modulation to enhance optimized medical therapy and improve cardiac remodeling in advanced heart failure: a case report.avi by Lina Feng (509270)

    Published 2025
    “…Background<p>Guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) has been demonstrated to significantly reduce morbidity and mortality. However, many patients, especially those with advanced HFrEF, are unable to tolerate optimal GDMT due to hypotension. …”
    Save to List
    Saved in:
  2. 19422
    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  3. 19423
    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  4. 19424
    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  5. 19425
    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  6. 19426
    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  7. 19427
    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  8. 19428
    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  9. 19429
    Table 2_Changes in rat plasma proteomes during the first week after birth.xlsx

    Table 2_Changes in rat plasma proteomes during the first week after birth.xlsx by Lilong Wei (426321)

    Published 2025
    “…The plasma of first-week rats, compared to that in newborn rats using label-free quantification, showed that the levels of 42 proteins significantly increased while those of 17 proteins decreased. …”
    Save to List
    Saved in:
  10. 19430
    Supplementary Material for: Genetical predicted causal relationship between gut microbiota and different types of kidney diseases

    Supplementary Material for: Genetical predicted causal relationship between gut microbiota and different types of kidney diseases by figshare admin karger (2628495)

    Published 2025
    “…Butyricicoccus, Catenibacterium, Flavonifractor, and Lachnospira were associated with an increased risk of membranous nephropathy, while RuminococcaceaeUCG011 was associated with a decreased risk of membranous nephropathy. …”
    Save to List
    Saved in:
  11. 19431
    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analysis based on the global burden of disease study 2021.docx

    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. …”
    Save to List
    Saved in:
  12. 19432
    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analysis based on the global burden of disease study 2021.docx

    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. …”
    Save to List
    Saved in:
  13. 19433
    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analysis based on the global burden of disease study 2021.docx

    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. …”
    Save to List
    Saved in:
  14. 19434
    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analysis based on the global burden of disease study 2021.docx

    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. …”
    Save to List
    Saved in:
  15. 19435
    Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analysis based on the global burden of disease study 2021.docx

    Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. …”
    Save to List
    Saved in:
  16. 19436
    <b>Phenological changes mediated the effects of nitrogen enrichment on reproduction in an alpine meadow on the Tibetan Plateau</b>

    <b>Phenological changes mediated the effects of nitrogen enrichment on reproduction in an alpine meadow on the Tibetan Plateau</b> by Tianwu Zhang (22122382)

    Published 2025
    “…Specifically, while N addition directly decreased flower production, it indirectly increased fruit set via phenological changes.…”
    Save to List
    Saved in:
  17. 19437
    Supplementary Material for: Exploring the ability of novel choroidal biomarkers in predicting treatment outcomes of polypoidal choroidal vasculopathy

    Supplementary Material for: Exploring the ability of novel choroidal biomarkers in predicting treatment outcomes of polypoidal choroidal vasculopathy by Zhang Y. (2828780)

    Published 2024
    “…The greater change of central macular thickness (CMT) was significantly correlated with increased CMT (P=0.030), decreased CT (P=0.042) and decreased CVI (p=0.038) at baseline. …”
    Save to List
    Saved in:
  18. 19438
    Evolutionarily conserved and functionally important amino acids in Artemis.

    Evolutionarily conserved and functionally important amino acids in Artemis. by Ziwen Huang (17562948)

    Published 2025
    “…<b>(D)</b> Several mutations of human Artemis found in ClinVar decreased its activity in CJ formation after cleavage of MmuRAG1/2 in 293T<sup><i>Artemis−/−</i></sup> cells. …”
    Save to List
    Saved in:
  19. 19439
    ChatGPT in CKD: Using Artificial Intelligence for Health Literacy

    ChatGPT in CKD: Using Artificial Intelligence for Health Literacy by Oscar Yasser Pena Zapata (19959306)

    Published 2024
    “…The most notable simplification was in one question, where the readability score decreased from 11.8 to 5.2. …”
    Save to List
    Saved in:
  20. 19440
    Impact of COVID-19 on early intervention referrals (Zellner et al., 2025)

    Impact of COVID-19 on early intervention referrals (Zellner et al., 2025) by Matthew A. Zellner (12043395)

    Published 2025
    “…The impact of COVID-19 on early intervention referrals and enrollments: An interrupted time series analysis. <i>American Journal of Speech-Language Pathology</i>, <i>34</i>(4), 2334–2341. …”
    Save to List
    Saved in:

Search Tools: